Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type I (PAI-1) in an athymic mouse model

Blood

Volumn 90, Issue 7, 1997, Pages 2738-2746

  Ma, Ding ^b   Gerard, Robert D ^b   Li, Xiao Yan ^b   Alizadeh, Hassan ^b   Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GENE DISRUPTION; GENE TRANSFER; HUMAN; HUMAN CELL; MELANOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UVEA TUMOR; VIRUS REPLICATION;

EID: 0030815119     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.7.2738.2738_2738_2746     Document Type: Article

References (40)

1. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM: Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 32:239, 1988
2. Gamel JW, Mclean IW, McCurdy JB: Biologic distinctions between cure and time to death in 2892 patients with intraocular melanoma. Cancer 71:2299, 1993
3. Donoso LA, Berd D, Augsburger JJ, Mastrangelo MJ, Shields JA: Metastatic uveal melanoma. Pretherapy serum liver enzyme and liver scan abnormalities. Arch Ophthalmol 103:796, 1985
4. Albert DM, Niffenegger AS, Willson JKV: Treatment of metastatic uveal melanoma: Review and recommendations. Surv Ophthalmol 36:429, 1992
5. Shields JA: Management of uveal melanoma. A continuing dilemma. Cancer 72:2067, 1993
6. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139, 1985
7. Vassalli JD, Sappino AP, Belin D: The plasminogen activator/ plasmin system. J Clin Invest 88:1067, 1991
8. Testa JE, Quigley JP: The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Met Rev 9:353, 1990
9. Bizik J, Lizonov A, Stephens RW, Vaheri A: Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion. Cell Regul 1:895, 1990
10. Kirchheimer JC, Wojta J, Christ G, Binder BR: Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line. Proc Nat Acad Sci USA 86:5424, 1989
11. De Vries T, Mooy CM, van Balken MR, Luyten GPM, Quax PHA, Verspaget HW, Weidle UH, Ruitter DJ, van Muijen GNP: Components of the plasminogen activation system in uveal melanoma-a clinico-pathological study. J Pathol 175:59, 1995
12. Sprengers ED, Kluft C: Plasminogen activator inhibitors. Blood 69:381, 1987
13. Soff GA, Sanderowitz J, Gately S, Verrusio E, Weiss I, Brem S, Kwaan HC: Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model. J Clin Invest 96:2593, 1995
14. Alizadeh H, Ma D, Berman M, Bellingham D, Comertord SA, Gething M-JH, Sambrook JF, Niederkorn JY: Tissue-type plasminogen activator-induced invasion and metastasis of murine melanomas. Curr Eye Res 14:449, 1995
15. Mueller BM, Yu YB, Laug WE: Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice. Proc Natl Acad Sci USA 92:205, 1995
16. Eitzman DT, Krauss JC, Shen T, Cui J, Ginsburg D: Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma. Blood 87:4718, 1996
17. van Doren K, Hanahan D, Gluzman Y: Infection of eucaryotic cells by helper-independent recombinant adenoviruses: Early region 1 is not obligatory for integration of viral DNA. J Virol 50:606, 1984.
18. Gerard RD, Meidel RS: Adenovirus-mediated gene transfer. Trends Cardiovascular Med 3:171, 1993
19. Herz J, Gerard RD: Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 90:2812, 1993
20. Budenz DL, Bennett J, Alonso L, Maguire A: In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest Ophthalmol Vis Sci 36:2211, 1995
21. Li T, Adamian M, Roof DJ, Berson EL, Dryja TP, Roessler BJ, Davidson BL: In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest Ophthalmol Vis Sci 35:2543, 1994
22. Jomary C, Piper TA, Dickson G, Couture LA, Smith AE, Neal MJ, Jones SE: Adenovirus-mediated gene transfer to murine retinal cells in vitro and in vivo. FEBS Lett 347:117, 1994
23. Abraham NG, da Silva J-L, Lavrovsky Y, Stoltz RA, Kappas A, Dunn MW, Schwartzman ML: Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest Ophthalmol Vis Sci 36:2201, 1995
24. Bennett J, Wilson J, Sun D, Forbes B, Maguire A: Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci 35:2535, 1994
25. Kan-Mitchell J, Mitchell MS, Rao N, Liggett PE: Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci 30:829, 1989
26. Anand R, Ma D, Alizadeh H, Comerford SA, Sambrook JF, Gething M-JH, McLean IW, Niederkorn Y: Characterization of intraocular tumors arising in transgenic mice. Invest Ophthalmol Vis Sci 35:3533, 1994
27. Niederkorn JY, Streilein JW, Shadduck JA: Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice. Invest Ophthalmol Vis Sci 20:355, 1981
28. Gerard RD, Meidel RS: Adenovirus vectors, in Hames BD, Glover D (eds): In DNA Cloning-A Practical Approach: Mammalian Systems. Oxford, UK, Oxford University Press, 1995, p 285
29. Riedo FX, Munford RS, Campbell WB, Reisch JS, Chien KR, Gerard RD: Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prostacyclin, and prostaglandin E2 induction by lipopolysaccharide but not by tumor necrosis factor-alpha. J Immunol 144:3506, 1990
30. Ma D, Luyten GP, Luider TM, Niederkorn JY: Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci 36:4435, 1995
31. Ma D, Niederkorn JY: Efficacy of tumor-infiltrating lymphocytes in treatment of hepatic metastases arising from transgenic intraocular tumors in mice. Invest Ophthalmol Vis Sci 36:1067, 1995
32. Harlow E, Crawford LV, Pim DC, Williamson NM: Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol 39:861, 1981
33. Saksela O: Radial caseinolysis in agarose: A simple method for detection of plasminogen activator in the presence of inhibitory substances and serum. Anal Biochem 111:276, 1981.
34. Mitra MM, Alizadeh H, Gerard R, Niederkorn JY: Characterization of a plasminogen activator produced by Acanthamoeba castlellanii. Mol Biochem Parasitol 73:157, 1995
35. Reilly D, Christensen L, Duch M, Nolan N, Duffy MJ, Andreasen PA: Type-1 plasminogen activator inhibitor in human breast carcinomas. Int J Cancer 50:208, 1992
36. Declerck PJ, Verstreken M, Collen D: Measurement of different forms of plasminogen activator inhibitor 1 (PAI-1) using various monoclonal antibody-based enzyme-linked immunosorbent assays. Fibrinolysis Supp 2:132, 1990
37. Ellis V, Wun T-C, Behrendt N, Ronne E, Dano K: Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. J Biol Chem 265:9904, 1990
38. 3, binding to vitronectin. Nature 383:441, 1996
39. Marshall E: Gene therapy's growing pains. Science 269:1050, 1995
40. Niederkorn JY: Immune privilege and immune regulation in the eye. Adv Immunol 48:191, 1990